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nimal models are defined as experimental
preparations developed in one species in order to study
phenomena existing in another species.When addressing
animal models of human psychopathology,attempts are
made to reproduce in animals some syndromes or symp-
toms resembling as far as possible some human syn-
dromes or symptoms in order to study particular aspects
of human psychopathology. When utilizing an animal
model for studying a human disease, it is important to
consider the validity of such a simulation.The validity of
animal models of psychiatric disorders is usually assessed
by different criteria:ideally,the model should resemble
the pathology it simulates in terms of its etiology,its biol-
ogy,its symptomatology,and its treatment.
1Three differ-
ent types of validity are usually considered: predictive
validity,aspect validity,and theoretical validity.
Predictive validity is determined by appropriate response
of the animal model to therapeutic agents.The model must
discriminate clinically efficacious agents from those which
are not.The simulation should identify substances that ame-
liorate,but also those that deteriorate the simulated pathol-
ogy.In addition,the model must be responsive to all cate-
gories of medications used to treat the simulated condition.
Aspect validity refers to phenomenological similarity
between the model and the pathology being simulated.It
mainly relates to symptomatology and mode of treatment.
Usually,models focus on one particular symptom of a given
disorder.The difficulty is to appreciate the importance of
this particular symptom in the definition of the syndrome.
Concerning the treatment,most psychotropic drugs need
to be regularly administered over several weeks or months.
Consequently,in the model,substances should continue to
be efficacious after chronic administration.In addition,and
similar to what happens in the clinic, we might expect a
delay in the appearance of the first beneficial effects.
Finally, evaluating the theoretical validity of an animal
model consists in identifying the behavioral variable that
will be simulated,estimating its degree of homology with
the behavior in the simulation,and appreciating the mean-
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One of the two core symptoms of depression is anhedo-
nia, the loss of interest or pleasure in daily activities.
Stressful life events are recognized as predisposing factors
in the etiology of depression. Rats subjected to a chronic,
mild, unpredictable stress regimen exhibit behavioral
deficits consistent with a loss of responsiveness to reward,
such as decreased sucrose consumption, decreased ability
to associate rewards with a distinctive environment, and
decreased sensitivity to rewarding electrical brain stimu-
lation. Normal behavior is restored by chronic treatment
with antidepressants or electroshocks. Chronically stressed
animals also exhibit sleep abnormalities resembling those
observed in depressed patients and recognized as bio-
logical markers of depression. Thus, stress-induced anhe-
donia in rats represents an original animal model of some
aspects of human depression offering convergent ele-
ments of biological, symptomatological, etiological, and
therapeutic validity. This simulation of depression may
prove useful for better understanding of the pathophys-
iological mechanisms involved in depressive disorders. 
Dialogues Clin Neurosci. 2002;4:351-360.ing of this variable in the context of the clinical situation.
Here,following a brief description of the symptomatol-
ogy and etiology of depression,we shall try to demon-
strate how to induce and how to measure an anhedonic
state in the laboratory rat.We shall summarize the main
experiments performed to validate this animal model of
depression by reviewing results from behavioral,phar-
macological,and electroencephalographic studies.
Symptomatology of depression
Depression is a very complex psychological disorder.
Many different symptoms can be present, but none by
itself is essential. An episode of major depression is
defined in the Diagnostic and Statistical Manual of
Mental Disorders,Fourth Edition (DSM-IV)
2 as follows:
Five (or more) of the following symptoms have been pre-
sent during the same 2-week period;at least one of the
symptoms is either depressed mood (1) or loss of inter-
est or pleasure (2).
• (1) Depressed mood.
• (2) Markedly diminished interest or pleasure in daily
activities.
• (3) Significant weight loss or weight gain (more than 5%
of body weight in a month),or decrease or increase
in appetite.
• (4) Insomnia or hypersomnia nearly every day.
•(5) Psychomotor agitation or retardation nearly every day.
• (6) Fatigue or loss of energy nearly every day.
• (7) Feelings of worthlessness or excessive or inappro-
priate guilt.
• (8) Diminished ability to think or concentrate nearly
every day.
• (9) Recurrent thoughts of death, recurrent suicidal
ideation.
Among all these symptoms of depression,some can easily
be modeled in animals (body weight change,psychomotor
retardation), whereas others cannot (feelings of worth-
lessness or guilt,suicidal ideation).DSM-IV defines two
major symptoms for the diagnosis of a major depressive
episode,namely depressed mood and loss of interest or
pleasure (anhedonia).As depressed mood is a subjective
feeling measurable through verbal interviews,it appears
difficult to simulate and measure in animals.However,the
inability to feel pleasure,which is highly correlated to the
severity of the depressive episode,can be simulated in ani-
mals and measured through different behavioral para-
digms described below.Consequently,anhedonia appears
to be the most important symptom to reproduce in any
attempt to realistically simulate depression.
Etiological factors in depression
Numerous factors have been implicated in the etiology of
depression:psychological factors,such as adverse life events,
chronic stress,and negative experience during childhood;
personality traits,such as introversion and impulsivity;bio-
logical factors,such as genetic background;and a series of
physical diseases and medications.
3,4 In certain cases,pre-
cipitating factors can be clearly identified as,for instance,in
seasonal affective disorders or postpartum depression.
However,in most cases,depression seems to result from the
accumulation of several different risk factors.
5
The probability of entering into a depressive episode is
increased 5 to 6 times during the 6-month period following
the appearance of stressful events.
6A chronic mild stress
regimen is recognized as a particularly powerful predispos-
ing factor.
7 Unemployment and financial difficulties are
associated with a high risk of depression.This type of events
(uncontrollable stress) can generate feelings of worthless-
ness and guilt (symptoms of a major depressive episode)
resulting in an inability to react.This type of chronic,low-
grade stress is a more efficacious precipitant of depression
than intense acute stressors.
4 One of the most significant
effects of stress is a decreased performance in motivated
behaviors.The hypothesis according to which depression
results from a reduction in the activity of the reward systems
is central to a number of theories on depression.In addition,
the inability to react to normally pleasant events constitutes
one of the two core symptoms of depression.
8Thus,demon-
stration in rats of a chronic, mild, unpredictable stress-
induced decrease in reward offers one of the most appro-
priate simulations of some aspects of human depression.
Chronic mild stress-induced anhedonia in rats
In order to develop a realistic simulation of depressive
states in animals,a double problem has to be solved:how
to induce an anhedonic state in laboratory rats,and how to
adequately and reproducibly measure this anhedonic state.
How can an anhedonic state be induced in the 
laboratory rat?
In 1981,Katz and collaborators developed a procedure
whereby rats were submitted to a variety of chronic,
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in cold water,tail pinch,etc.Following a week of such a
stress regimen,animals exhibited behavioral deficits and
hormonal changes that could be prevented by adminis-
tration of antidepressants,but not by other psychotropic
substances. Unlike control animals, the chronically
stressed animals did not increase drinking when saccha-
rine or sucrose was added to their drinking water to
enhance palatability.
9,10This observation was particularly
important as it implied that this chronic stress regimen
was able to induce dysfunctioning of the reward systems.
This abnormality in the drinking behavior could reflect
the development of an anhedonic state in animals.
Later,Willner adapted this procedure by using less severe
stressors which were supposed to provide a better analogy
with mild unpredictable stressors encountered in daily life.
11
Rats exposed to such a mild stress procedure progressively
develop a reduced sensitivity to reward as evaluated by
reduction in sucrose consumption.This behavioral deficit
could be restored by chronic treatment with antidepressants.
Considering that chronic low-grade stressors are an impor-
tant factor in the etiology of depression,we have adapted
Willner’s procedure to our laboratory needs.This stress pro-
cedure used in all experiments reported here is described
in Table I.
12
How can an anhedonic state be evaluated in laboratory
rats? 
Different behavioral paradigms can be used to evaluate
sensitivity to reward in animals: sucrose consumption,
place conditioning,and self-stimulation behavior.
Initially, Willner used sucrose consumption measure-
ment.He showed that the chronic mild stress procedure
induced a substantial reduction in consumption and/or
preference of sucrose solutions.
11 This reduction was
interpreted as reflecting a decreased sensitivity to reward
in stressed animals.However,sucrose consumption can
vary from one experiment to another and can be influ-
enced by body weight loss resulting from the stress.
13
Papp et al
14 have used the place preference paradigm to
study the stress effects on reward induced by sweet solu-
tions or amphetamine.In this paradigm,pleasure intensity
is monitored by the preference exhibited by the animals
for an environment previously associated with appetitive
properties of food or amphetamine.These authors have
shown that chronic mild stress elicited a decrease in the
place preference behavior,which was interpreted as indi-
cating an altered response to pleasure.However,these data
could also be explained by a reduced ability of stressed ani-
mals to associate reinforcing stimulus with the environ-
ment where this stimulus is presented.Deficits in associa-
tive learning have been observed in animals exposed to
electric shocks
15 and subtle alterations of attention induced
by “nonpertinent”stimuli have also been reported.
16
Self-stimulation behavior is a very useful way for studying
positive reinforcements and motivational or hedonic states.
The self-stimulation technique allows a rat implanted with
an electrode in a particular reward area of the brain to self-
administer weak electrical pulses. Such stimulation can
have very intense reinforcing properties.Thus,the greater
the rewarding properties of the stimulation,the more the
rat will self-stimulate.The threshold for self-stimulation
behavior can thus be used as an index of its hedonic/anhe-
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Table I. Chronic, mild, unpredictable stress procedure.
Reproduced from reference 12: 5-HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropyschopharmacol. 1996;6:169-175.
Copyright © 1996, Elsevier Science.
Morning Afternoon
Monday 8 AM 1-h confinement in restricted space 1 PM 1-h confinement in restricted space
4 PM overnight illumination
Tuesday 8 AM self-stimulation 2 PM 1-h confinement in restricted space
11 AM 1-h confinement in restricted space 4 PM food and water deprivation for 18 h
Wednesday 8 AM access to restricted food for 2 h 1 PM 1-h confinement in restricted space
4 PM water deprivation for 18 h
Thursday 8 AM exposure to empty bottle for 1 h 2 PM 1-h confinement in restricted space
11 AM 1-h confinement in restricted space 4 PM group-housed in soiled cage for 18 h
Friday 8 AM self-stimulation
11 AM 1-h confinement in restricted space 4 PM reversed light/dark cycle throughout the weekenddonic state.
17An increase in this threshold will indicate a
decreased sensitivity to reward.By allowing stimulation of
the mesocorticolimbic structures,it is possible to obtain
very intense self-stimulation behavior because this stimu-
lation activates directly the neuronal substrates involved
in motivational processes.In our model,self-stimulation
behavior induced by activation of the ventral tegmental
area was used because corticolimbic projections of this
brain structure constitute the main source of the dopamin-
ergic innervation of the brain,which plays a major role in
motivational and rewarding processes.
18
Effects of chronic mild stress on sensitivity to
pleasure in rats
By using a chronic,unpredictable,mild stress regimen as the
etiological factor and variations of ventral tegmentum self-
stimulation threshold as the anhedonia scale,it was shown
that rats exposed for 3 weeks to such a stress regimen exhib-
ited an increase in self-stimulation threshold (Figure 1),ie ,
a decrease in their sensitivity to pleasure.This effect pro-
gressively developed over the first 2 weeks of stress,lasted
until the end of the stress period,and gradually disappeared
thereafter. Nonstressed animals did not develop such an
anhedonic state.This increase in self-stimulation threshold
is compatible with a decrease in the reinforcing efficacy of
the stimulation,reflecting the gradual development of an
anhedonic state induced by stress.The decreased sensitivity
to reinforcing stimuli as well as the progressive development
of stress effects resemble certain aspects of depression in
man.These observations already provide this animal model
of depression with a certain degree of theoretical validity.
Validation of the anhedonia model
Predictive validity
The next step consisted in verifying whether the various
types of clinically effective antidepressant treatments
would be active in this model,and whether medications
failing to have antidepressant effects (such as anxiolytics,
antipsychotics,and analgesics) would be inactive.Several
representative drugs of the different classes of antide-
pressants were tested with respect to their preventative
or curative effects on stress-induced anhedonia.When
rats were stressed and simultaneously treated with a tri-
cyclic antidepressant drug (desipramine
19) or a type A
monoamine oxidase (MAO) inhibitor (moclobemide
20),
the anhedonia index did not vary (as in nonstressed ani-
mals), whereas stressed placebo-treated rats progres-
sively developed an anhedonic state (Figure 2).
These substances prevent the development of a hedonic
deficit in stressed rats whereas they remain without effect
in nonstressed animals.These results are in line with clin-
ical observations.Indeed,tricyclic antidepressants and
MAO inhibitors are effective in depressed patients but
do not modify mood in nondepressed individuals.
These first experiments used preventative treatments.This
type of manipulation does not optimally simulate the clin-
ical situation where patients consult a practitioner once
they are already depressed and should therefore undergo
a curative therapy.Thus,the predictive validity of this ani-
mal model was further tested by evaluating a curative
treatment with a representative of the atypical antide-
pressants (mianserin
21).As shown in Figure 3 (upper part),
the chronic mild stress procedure resulted in an increase
in self-stimulation threshold in both groups of stressed
rats.This anhedonia progressively developed over 2 weeks
to then reach a plateau.When stressed anhedonic animals
were treated with mianserin from day 22 to day 38 of the
stress period, the increase in self-stimulation threshold
was completely abolished after about 10 days of treat-
ment.When stressed anhedonic rats were treated with
placebo during the same period of time,their anhedonic
state did not normalize.This experiment has proven that
this animal model was able to detect a further category of
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Figure 1. Anhedonia induced by a chronic mild stress regimen in rats.
Variations in self-stimulation threshold in stressed (blue squares)
and nonstressed (open circles) animals are shown as a function
of stress exposure time (shaded area). Asterisks indicate sta-
tistically significant difference (Student t test, P<0.05) with base-
line value measured before the stress period (day 0). 
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*antidepressant drugs and was appropriately responding
to curative treatment of the anhedonic state.
In summary, these pharmacological experiments have
demonstrated two important features:(i) chronic treatment
is necessary to obtain an adequate antidepressant effect in
stressed animals;and (ii) in nonstressed rats,the antide-
pressant treatment does not modify the self-stimulation
behavior.These observations point to the similarity with
the clinical situation where (i) in depressed patients,at least
2 to 3 weeks of treatment are necessary before observing a
significant mood improvement; and (ii) antidepressant
drugs do not modify mood in nondepressed individuals.
These pharmacological data allow chronic mild stress-
induced anhedonia in rats to be considered as a simulation
of human depression exhibiting a fair predictive validity
for drug therapy of affective disorders.In order to further
substantiate this validity,we tested the effects of a non-
pharmacological treatment of depression, namely elec-
troshock therapy.This treatment is used in severe cases of
depression not responding to classic antidepressant med-
ication.Electroshock therapy is recognized as being more
efficacious and more rapidly acting than chemotherapy.
22,23
Thus,we tested the effects of electroshock treatment in
anhedonic rats.
24 Results are presented in Figure 4.
In both groups of animals,the stress regimen induced an
anhedonic state that gradually developed over a 2-week
period.When “depressed”animals were submitted to an
electroshock on day 21, their anhedonic state was com-
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Figure 2. Preventative effects of a monoamine oxidase inhibitor (moclobe-
mide, 20 mg/kg bid intraperitoneally) on stress-induced anhe-
donia. Top: Variations in self-stimulation threshold in stressed
rats administered of moclobemide (blue squares) or placebo
(open circles) as a function of stress exposure time (shaded area).
Bottom: Variations in self-stimulation threshold in nonstressed
moclobemide (blue squares) or placebo (open circles)–treated
rats.
20 *Significantly different from prestress control values. 
Reproduced from reference 20: Moreau JL, Jenck F, Martin JR, Motas P, Haefely
W. Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a
novel animal model of depression. Pharmacopsychiatry. 1993;26:30-33. Copyright
© 1993, Thieme Medical Publishers.
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Figure 3. Curative effects of an atypical antidepressant (mianserin, 5 mg/kg
intraperitoneally) on stress-induced anhedonia. Top: Variations in
self-stimulation threshold in stressed (day 0 to day 38) rats treated
(day 22 to day 38) with mianserin (blue squares) or placebo (open
circles) as a function of stress exposure time (shaded area). Bottom:
Variations of self-stimulation threshold in nonstressed rats treated
(day 22 to day 38) with mianserin (blue squares) or placebo (white
circles).
21 *Significantly different from prestress control values. 
Reproduced from reference 20: Moreau JL, Bourson A, Jenck F, Martin JR, Mortas P.
Curative effects of the atypical antidepressant mianserin in the chronic mild stress-
induced anhedonia model of depression. J Psychiatry Neurosci. 1994;19:51-56.
Copyright © 1994, Canadian Medical Association.
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*pletely and very rapidly reversed.In contrast,anhedonia of
stressed animals submitted to sham shocks was not signif-
icantly diminished.Electroshock treatment was found to be
much more rapid than antidepressant medications.These
results provide an interesting parallel with the clinical situ-
ation where, in certain cases, nonresponder depressed
patients exhibited a rapid and profound mood elevation fol-
lowing electroconvulsive therapy.Indeed,it has long been
known that patients responding to electroshocks often
exhibit a rapid loss of their depressive symptomatology.
25
A final step in evaluating the predictive validity of this sim-
ulation consisted in verifying its specificity for antidepres-
sant treatments.To this purpose,the effects of the antipsy-
chotic drug risperidone were evaluated in stressed animals.
As shown in Figure 5,
26 all stressed rats developed an
anhedonic state,whether they were treated with placebo
or with risperidone. Preventative treatment with this
antipsychotic drug remained inefficient in suppressing
stress-induced anhedonia.Risperidone by itself increased
self-stimulation threshold in nonstressed animals.This
could explain the loss of an antianhedonic effect in
stressed animals.Risperidone blocks both dopaminergic
D2 and serotonergic 5-HT2 receptors.Numerous studies
have shown that antidopaminergic drugs (neuroleptics)
decrease the self-stimulation threshold in naive animals.
However,this property is unlikely to explain the lack of
effect of risperidone on stress-induced anhedonia, as
mianserin abolished this anhedonia and decreased self-
stimulation behavior in nonstressed animals These varia-
tions in self-stimulation thresholds in nonstressed rats
most probably reflect subtle motor and/or cognitive
deficits induced by those substances.
In summary,the results presented above have shown that
the stress-induced anhedonia model is able to demonstrate
the activity of electroshock and antidepressant drugs rep-
resenting different biochemical mechanisms of action,
whereas an antipsychotic drug was inactive.In addition,
other related studies have shown that treatment with a
tranquilizer (chlordiazepoxide),an analgesic (morphine),
neuroleptics (haloperidol,chlorprothixene),or a psycho
Basic research
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Figure 4. Curative effects of electroshock treatment on stress-induced anhe-
donia.Variations of self-stimulation threshold in stressed (from day
1 to day 33) rats treated (from day 21 to day 33) with 6 elec-
troshocks (open circles) or sham shocks (blue squares) as a func-
tion of stress exposure time (shaded area).
24 *Significantly differ-
ent from prestress control values. 
Reproduced from reference 24: Moreau JL, Scherschlicht R, Jenck F, Martin JR. Chronic
mild stress-induced anhedonia model of depression: sleep abnormalities and curative
effects of electroshock treatment. Behav Pharmacol. 1995;6:682-687. Copyright ©
1995, Lippincott, Williams & Wilkins.
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Figure 5. Lack of effect of an antipsychotic (risperidone) on stress-induced
anhedonia.
26 Top: Variations of self-stimulation threshold in stressed
rats treated with risperidone 0.3 mg/kg bid intraperitoneally (blue
squares) or placebo (open circles) as a function of stress exposure time
(shaded area). Bottom: Variations in self-stimulation threshold in
nonstressed animals treated with risperidone 0.3 mg/kg bid intraperi-
toneally (blue squares) or placebo (open circles). *Significantly differ-
ent from prestress control values. 
Reproduced from reference 26: Moreau JL, Jenck F, Martin JR. Simulation of a core symp-
tom of human depression in rats. Curr Topics Pharmacol. 1998;4:37-50. Copyright © 1998,
Research Trends.
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*stimulant (amphetamine) also failed to reduce stress-
induced anhedonia in rats.
27,28 Therefore, the anhedonia
model offers a fair degree of predictive validity.This sim-
ulation of depression should allow, on the one hand, to
detect novel types of substances acting on depressed mood
to be developed,and,on the other hand,the rapidity of
onset of those medications to be predicted.
Theoretical validity and aspect validity 
Evaluating the theoretical and aspect validities of a sim-
ulation of depression consists in examining the degree of
resemblance of the model with the syndrome it is sup-
posed to reproduce. Ideally, an animal model should
resemble the disease it simulates with regard to its etiol-
ogy,symptomatology,treatment,and biological basis.In
addition,a heuristic animal model should exhibit similar-
ities with the core symptoms of a pathology rather than
with the secondary symptoms.
Anhedonia, a core symptom of depression
As mentioned earlier,DSM-IV defines two core symptoms
in the diagnosis of a depressive episode:depressed mood
(a subjective feeling impossible to simulate in animals) and
anhedonia.The choice of anhedonia as an essential char-
acteristic of this model provides this simulation with a
remarkable aspect validity. Moreover, this simulation
exhibits other similarities with depression.First,it can show
a curative effect of antidepressant treatment on hedonic
deficit,and not only a prophylactic effect.Second,the stress
regimen continues during the treatment period, like the
clinical situation,as there is usually no major change in the
life conditions of a depressed patient that could be associ-
ated with treatment.Third,the time course of the antide-
pressant effect (10 to 20 days) in the anhedonia model cor-
responds to the time course observed clinically.Finally,no
change is observed in control animals, as is the case for
healthy volunteers in which antidepressants remain with-
out effect on mood.
The chronic, mild, unpredictable stress regimen
This model also offers a realistic simulation of depression,
because it utilizes a chronic, mild, unpredictable stress
procedure.Many studies have involved chronic mild stres-
sors as important factors for the genesis of a depressive
episode. Moreover, it has been shown that the conse-
quences of mild stressors are exacerbated after a stressful
life event.
29The anhedonia simulation in rats offers a rea-
sonable approximation of stressful events encountered in
daily life.The more conventional stress models,which use
only one confrontation with severe stressors, seem less
appropriate to reproduce certain aspects of depression.
In summary,this simulation can be considered as provid-
ing a better aspect validity with respect to the etiological
role of stressful life events,compared with models using
acute and more severe stressors.
Biological markers of depression
We have also shown that the regimen of chronic mild stress
used in this simulation was able to induce abnormalities in
certain sleep parameters.
24 As shown in Figure 6, such a
stress regimen elicits a decrease in the latency to the first
episode of paradoxical rapid eye movement (REM) sleep,
as well as an increase in the number of episodes of this sleep
stage.These abnormalities progressively develop as they
appear only 2 weeks after initiation of the stress regimen.
These results are important because they reproduce clini-
cal findings. Indeed, several studies have shown sleep
abnormalities in depressed patients.
30-33These abnormali-
ties also consist in a decreased latency for REM sleep and
an increase in its frequency.These abnormalities are con-
sidered by a number of clinicians as biological markers of
depression.A decrease in REM sleep latency is perhaps the
most frequent observation performed in depressed
patients.
34,35 It is recognized as a potential marker for
endogenous depression.
In summary,the stress-induced anhedonia model exhibits
a solid aspect validity in its etiology,symptomatology,treat-
ment, and biological bases.The results clearly suggest a
causal relationship between chronic mild stress and the
anhedonia symptom.This relationship has been confirmed
by a study in humans that showed that endogenous
depressed patients experience the severity of stressful
events in an exaggerated manner.
36The clinical confirma-
tion of a direct relationship between chronic mild stress and
anhedonia reinforces the validity of the simulation and its
heuristic value.
Conclusion
The similarities between the stress-induced anhedonia model
in rats and certain aspects of depressive disorder in humans
are illustrated by the following main results (Table II).
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The stress procedure used in these studies was able to
induce a decrease in sucrose consumption and/or pref-
erence,a decrease in the ability to associate pleasurable
events with a particular environment (place preference),
and an increase in the current threshold necessary to
elicit self-stimulation behavior.These results obtained by
different research groups using different strains of ani-
mals strengthen the idea that a chronic, mild, unpre-
dictable stress regimen induces a decreased sensitivity to
pleasure,ie,an anhedonic state.Anhedonia is one of the
two core symptoms of depression.
Aspect validity
In addition to inducing an anhedonic state,the chronic mild
stress regimen triggers the development of several other
symptoms of depression.Indeed,it is able to decrease sex-
ual and aggressive behavior,
37 inhibit locomotor activity,
and induce a phase advance shift in circadian rhythm,
41
elicit a body weight loss, hypertrophy of the adrenals,
26
hypersecretion of corticosterone,
38 and sleep abnormali-
ties.
24 However,this stress regimen did not induce particu-
lar anxiety symptoms in two animal models of anxiety,the
elevated plus-maze and the social interaction tests.
37
Therefore, this simulation elicits behavioral and physio-
logical abnormalities found in depression,and these effects
seem to have some specificity for depressive-like behaviors.
Predictive validity
The different types of antidepressant drugs did not modify
reinforced behaviors in control nonstressed animals.
Medications effective in antagonizing stress-induced anhe-
donia include representatives of the tricyclics
11,19
monoamine reuptake inhibitors such as fluoxetine and
maprotiline,
27 inhibitors of monoamine oxidase such as
moclobemide and brofaromine,
20,28 and atypical antide-
pressants such as mianserin.
21,39 Electroconvulsive shocks
24
and lithium
40 are also active in this model.The antagonism
of stress-induced anhedonia requires 2 to 4 weeks of treat-
ment,similar to the time course of antidepressant drugs in
humans.Inefficacious substances include representatives of
tranquilizers such as chlordiazepoxide
27;antipsychotics such
as risperidone (see above),haloperidol,and chlorprothix-
ene;psychostimulants such as amphetamine;and analgesics
such as morphine.
28Therefore,this simulation appears as
specific and selective in its response to all categories of clin-
ically used antidepressant treatments, and in its lack of
response to other nonantidepressant psychotropics.
In conclusion,among all animal models of depression,
stress-induced anhedonia is probably the best character-
ized simulation that most appropriately reflects certain
fundamental aspects of human depression. One of the
most important aspects of animal models is to suggest
hypotheses about the functioning and the involvement
of particular neurotransmission systems and/or particu-
lar brain areas in psychiatric disorders.
42 This model
should allow a better understanding of some of the
pathophysiological aspects of neuropsychiatric disorders
in which anhedonia plays an essential role. ❏
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Figure 6. Paradoxical sleep abnormalities in chronically stressed animals.
Decrease in latency and increase in number of episodes of para-
doxical sleep in rats exposed to the chronic mild stress proce-
dure for 3 weeks (dark blue bars) compared with control
unstressed animals (light blue bars).
24 REM, rapid eye move-
ment. *Significantly different from prestress control values.
Reproduced from reference 24: Moreau JL, Scherschlicht R, Jenck F, Martin JR. Chronic
mild stress-induced anhedonia model of depression: sleep abnormalities and cura-
tive effects of electroshock treatment. Behav Pharmacol. 1995;6:682-687. Copyright
© 1995, Lippincott, Williams & Wilkins.
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Table II. Similarities between main features of a depressive episode in man and chronic mild stress-induced anhedonia in rats. Data in animals are a
compilation of results found in the following publications: 11, 14, 19-21, 24, and 36-40. MAO, monoamine oxidase; SNRIs, selective
noradrenaline reuptake inhibitors; SSRIs, selective serotonin reuptake inhibitors.
Depression in man Anhedonia in rats
Symptoms • Depressed mood • Cannot be simulated
• Loss of interest or pleasure • Reduced sensitivity to reward
• Decreased sex drive • Decreased sexual activity
• Low self-esteem • Decreased aggressive behavior
Risk factors • Stressful life events • Chronic mild stress
• Social isolation in childhood • Isolation-reared animals are more vulnerable to 
chronic mild stress
Biological markers • Sleep abnormalities • Sleep abnormalities
• Corticosterone hypersecretion  • Corticosterone hypersecretion
Active treatments • Tricyclics • Amitriptyline, imipramine, desipramine
• Atypicals • Maprotiline, mianserin
• SSRIs • Fluoxetine, citalopram, sertraline
• SNRIs • Venlafaxine
• MAO inhibitors • Moclobemide, brofaromine
• Electroconvulsive therapy • Electroshock treatment
Ineffective treatments • Anxiolytics • Chlordiazepoxide
• Psychostimulants • Amphetamine
• Antipsychotics • Risperidone, haloperidol, chlorprothixene
• Analgesics • Morphine
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Simulación del síntoma depresivo 
anhedonia en animales
Uno de los dos síntomas centrales en la depresión
es la anhedonia, la pérdida del interés o del placer
en las actividades diarias. Se ha reconocido que los
acontecimientos vitales estresantes actúan como
factores predisponentes en la etiología de la depre-
sión. Las ratas sometidas a una situación de estrés
crónico, leve e impredecible exhiben déficits con-
ductuales que consisten en una pérdida de sensibi-
lidad ante la recompensa, tales como disminución
en el consumo de sucrosa, disminución de la capa-
cidad para asociar recompensas con un ambiente
característico y una sensibilidad disminuida a la esti-
mulación eléctrica cerebral gratificante. La conducta
normal se restituye mediante el tratamiento crónico
con antidepresivos o electrochoques. Los animales
estresados crónicamente también presentan tras-
tornos del sueño que recuerdan lo que se ha obser-
vado en pacientes depresivos y que se ha recono-
cido como marcadores biológicos de la depresión.
De este modo, la anhedonia inducida por el estrés
en las ratas representa un modelo animal original
de algunos aspectos de la depresión en humanos y
ofrece elementos convergentes de validez biológica,
sintomatológica, etiológica y terapéutica. Esta simu-
lación de la depresión puede probar su utilidad para
una mejor comprensión de los mecanismos fisiopa-
tológicos involucrados en los trastornos depresivos.
Simulation chez l’animal de l’anhédonie,
symptôme de dépression
Un des deux principaux symptômes de la dépression
est l’anhédonie, ou manque d’intérêt ou de plaisir
dans les activités quotidiennes. Les événements stres-
sants de la vie sont reconnus comme des facteurs pré-
disposants dans l’étiologie de la dépression. Des rats
soumis à un régime de stress chronique, léger et
imprévisible montrent des déficits du comportement
importants compatibles avec une perte de réactivité
à la récompense, comme une diminution de la con-
sommation de sucre, une moins bonne capacité à
associer les récompenses avec un environnement par-
ticulier, et une diminution de la sensibilité à la stimu-
lation électrique récompensante du cerveau. Une
conduite normale est restaurée par un traitement
chronique par antidépresseurs ou électrochocs. Des
animaux stressés de façon chronique montrent éga-
lement des troubles du sommeil ressemblant à ceux
observés chez les patients déprimés et reconnus
comme des marqueurs biologiques de la dépression.
Ainsi, une anhédonie induite par le stress chez le rat
représente un modèle animal original de certains
aspects de la dépression humaine offrant des élé-
ments convergents de valeur biologique, symptoma-
tologique, étiologique et thérapeutique. Cette simu-
lation de la dépression peut se montrer utile pour une
meilleure compréhension des mécanismes physio-
pathologiques impliqués dans les troubles dépressifs.